| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/24/2002 | US20020010177 For treating eosinophil-dependent inflammatory diseases, asthma |
| 01/24/2002 | US20020010174 1,4-diazepine-2-one derivatives as neurokinin antagonist |
| 01/24/2002 | US20020010170 Pyrimido(1,6-b)pyridazine derivatives used as p38 inhibitors a mammalian protein kinase is involved in cell proliferation, cell death and response to extracellular stimuli |
| 01/24/2002 | US20020010150 Homostatic compositions of polyacids and polyalkylene oxides and methods for their use |
| 01/24/2002 | US20020010146 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 01/24/2002 | US20020009509 Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition |
| 01/24/2002 | US20020009508 Containing hydroxy acids |
| 01/24/2002 | US20020009483 Topical administration of oxazolidinones for transdermal delivery |
| 01/24/2002 | US20020009446 Method of modulating memory effector T-cells and compositions |
| 01/24/2002 | US20020009421 Oral administering cyclooxygenase inhibitor |
| 01/24/2002 | DE10033459A1 New aminomethyl-substituted bicyclic compounds, useful for treating urinary incontinence, pruritis, tinnitus, diarrhea or especially pain |
| 01/24/2002 | CA2418214A1 Antimicrobial agent |
| 01/24/2002 | CA2416248A1 5-substituted 2-aryl-4-pyrimidinones |
| 01/24/2002 | CA2416187A1 Use of 2.alpha.-methyl-19-nor-20(s)-1.alpha.,25-dihydroxyvitamin d3 to increase bone strength |
| 01/24/2002 | CA2416015A1 Matrix metalloproteinase inhibitors |
| 01/24/2002 | CA2415938A1 Alpha-msh related compounds and methods of use |
| 01/24/2002 | CA2415935A1 Novel 6-heteroarylphenanthridines |
| 01/24/2002 | CA2415701A1 Compositions and methods for the treatment of skin damage |
| 01/24/2002 | CA2415665A1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors |
| 01/24/2002 | CA2415557A1 Compounds for the treatment of sexual dysfunction |
| 01/24/2002 | CA2415285A1 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds |
| 01/23/2002 | EP1174450A1 Associative cationic polyurethanes and their use as thickeners |
| 01/23/2002 | EP1174151A1 Preventive or therapeutic drugs for various eosinophilia-related diseases containing chymase inhibitors as the active ingredient |
| 01/23/2002 | EP1174140A1 Skin preparations for external use |
| 01/23/2002 | EP1174130A2 Use of preparations of curcuma plants |
| 01/23/2002 | EP1174121A1 Composition comprising a Sophora japonica extract and its cosmetic use |
| 01/23/2002 | EP1174118A1 Use of inulin and derivatives thereof |
| 01/23/2002 | EP1174112A2 Hair cosmetic composition |
| 01/23/2002 | EP1174109A2 Combinations of active substances respectively adducts from cyclodextrins and at least a quinone and/or at least a hydroquinone and use of such combinations of active substances in cosmetic preparations |
| 01/23/2002 | EP1173767A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/23/2002 | EP1173569A1 Synthetic signalling molecules |
| 01/23/2002 | EP1173566A2 Human membrane-associated proteins |
| 01/23/2002 | EP1173485A1 Human antibodies to staphylococcus aureus |
| 01/23/2002 | EP1173484A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains |
| 01/23/2002 | EP1173479A1 49 human secreted proteins |
| 01/23/2002 | EP1173478A1 49 human secreted proteins |
| 01/23/2002 | EP1173477A1 49 human secreted proteins |
| 01/23/2002 | EP1173469A2 Adhesion modulatory peptides and methods for use |
| 01/23/2002 | EP1173468A1 Integrin receptor antagonists |
| 01/23/2002 | EP1173462A1 50 human secreted proteins |
| 01/23/2002 | EP1173451A1 New antioxidative vitamin b 6 analogs |
| 01/23/2002 | EP1173424A1 Pyrimidine compounds |
| 01/23/2002 | EP1173413A1 Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors |
| 01/23/2002 | EP1173403A1 Salts of asiatic and madecassic acid suitable for the preparation of pharmaceutical and cosmetic compositions |
| 01/23/2002 | EP1173273A1 Novel stable water-in-oil emulsions containing an emulsifier based on oleyl- and/or isostearyl-glycoside |
| 01/23/2002 | EP1173219A1 Non-aqueous liquid shampoo composition |
| 01/23/2002 | EP1173201A1 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 01/23/2002 | EP1173183A2 Use of compounds with a nitrogen-oxygen heterocycle |
| 01/23/2002 | EP1173170A1 Pyrrolidine modulators of chemokine receptor activity |
| 01/23/2002 | EP1173162A1 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions |
| 01/23/2002 | EP1173149A1 Cosmetic and/or dietetic composition comprising a mixture of lycopene and olive leaf extract |
| 01/23/2002 | EP1173147A2 Sunscreen agents containing hydroxycarboxylic acid alkyl,-and/or alkenyloligo- glycoside esters |
| 01/23/2002 | EP1173145A1 Composition for cosmetic and dermatological skin care |
| 01/23/2002 | EP1173071A1 Ginseng berry health products |
| 01/23/2002 | EP1173070A1 Cactus fruit health products |
| 01/23/2002 | EP1173061A1 Compositions and methods for treatment of hyperproliferative diseases |
| 01/23/2002 | EP1100444A4 Topical anionic salicylate for disorders of the skin |
| 01/23/2002 | EP0854711B1 gamma-RAR ANTAGONIST LIGAND OR alpha-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR |
| 01/23/2002 | EP0841898B1 Topical compositions having improved skin feel |
| 01/23/2002 | CN1332801A Connective tissue growth factor (CTGF) and methods of use |
| 01/23/2002 | CN1332740A 5HT antagonists for antidepressant therapy |
| 01/23/2002 | CN1332731A Substituted benzimidazoles and their prep. and use |
| 01/23/2002 | CN1332727A 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 01/23/2002 | CN1332722A 2-substituted Retoamides |
| 01/23/2002 | CN1332711A Vitamin D analogues |
| 01/23/2002 | CN1332648A Method of providing cosmetic/medical therapy |
| 01/23/2002 | CN1332240A Superoxide dismutase-4 |
| 01/23/2002 | CN1332012A Chinese medicine fumigant for treating vulval disease and its prepn |
| 01/23/2002 | CN1332011A Medicine for treating psoriasis, ichthyosis and eczema |
| 01/23/2002 | CN1332006A Leukoderma treating medicine |
| 01/23/2002 | CN1332003A External-use medicine for treating beriberi and its prepn process and usage thereof |
| 01/23/2002 | CN1332002A Acne treating capsule |
| 01/23/2002 | CN1331985A Dressing for treating scalds and burns and its prepn |
| 01/23/2002 | CN1331984A External-use trauma treating ointment |
| 01/23/2002 | CN1331982A Ointment (pellet) for eliminating wind-evil, diminishing inflammation and treating skin disease |
| 01/23/2002 | CN1331979A Bromhidrosis treating composite Chinese medicine and its dosage |
| 01/23/2002 | CN1331976A Traumtin prepn for injecta and its prepn process |
| 01/23/2002 | CN1078250C Reshaped monoclonal antibodies against immunoglobulin isotype |
| 01/23/2002 | CN1078084C Medicinal composition for treating psoriasis |
| 01/23/2002 | CN1078082C Medicine for acne and preparing method thereof |
| 01/23/2002 | CN1078077C Non-scar neutral burn ointment and its prep. |
| 01/22/2002 | US6340709 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing |
| 01/22/2002 | US6340706 Antiinflammatory, antiallergic and antiproliferative agents |
| 01/22/2002 | US6340694 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors |
| 01/22/2002 | US6340685 Antiinflammatory agents |
| 01/22/2002 | US6340680 Oxazinoquinolones useful for the treatment of viral infections |
| 01/22/2002 | US6340467 Useful as an ointment, balm or salve for wounds |
| 01/22/2002 | US6340458 Use of enzymes for skin expansion |
| 01/22/2002 | CA2259962C Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells |
| 01/22/2002 | CA2209188C Compositions for the treatment of dermatological disorders and methods for their use |
| 01/22/2002 | CA2051460C Pharmaceutical compounds |
| 01/22/2002 | CA2038398C Dna encoding a growth factor specific for epithelial cells |
| 01/22/2002 | CA2019974C Treatment of inflammation |
| 01/17/2002 | WO2002004612A2 Drug metabolizing enzymes |
| 01/17/2002 | WO2002004531A2 Process for preparing benzoxazin-4-one polymer conjugates |
| 01/17/2002 | WO2002004509A2 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
| 01/17/2002 | WO2002004499A1 Chemokine receptor modulators, production and use |
| 01/17/2002 | WO2002004490A2 Lipid metabolism molecules |
| 01/17/2002 | WO2002004487A2 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 01/17/2002 | WO2002004472A1 Novel compounds and methods |